Generic vs Brand Name Drugs

What Makes a Drug "Generic"?

A generic drug is a medication that has the same active ingredient, dosage form, strength, route of administration, and intended use as an already-approved brand name drug. When a pharmaceutical company develops a new drug, it receives a patent that typically lasts 20 years. Once that patent expires, other manufacturers can produce generic versions.

The FDA requires generic drugs to be bioequivalent to the brand name version, meaning they deliver the same amount of active ingredient into the bloodstream at the same rate. The agency's published bioequivalence window is typically 80–125% of the brand reference absorption rate. This page does not add a tighter "in practice" band that the NADAC extract does not measure.

What's the Same

• Active ingredient - the chemical compound that produces the therapeutic effect
• Dosage and strength - same milligrams of active drug per tablet, capsule, etc.
• Route of administration - same method (oral, topical, injectable, etc.)
• Safety and efficacy - must meet the same FDA standards
• Manufacturing quality - produced under the same Good Manufacturing Practice (GMP) standards
• Labeling - same warnings, contraindications, and side effect information

What Can Be Different

• Inactive ingredients - fillers, binders, dyes, and flavorings may differ (important for people with allergies or sensitivities)
• Appearance - color, shape, and size are often different due to trademark laws
• Name - generics use the drug's chemical name instead of a brand name
• Price - generics cost significantly less because manufacturers don't bear the original research and development costs
• Packaging - different manufacturer, different box

The FDA Approval Process for Generics

Generic drug manufacturers must submit an Abbreviated New Drug Application (ANDA) to the FDA. This process requires the manufacturer to prove:

1. The generic contains the same active ingredient as the brand name drug
2. It is bioequivalent (absorbed at the same rate and to the same extent)
3. It is manufactured under FDA-inspected facilities following GMP
4. The inactive ingredients are safe and don't affect the drug's performance
5. The label matches the brand name drug's approved labeling

The ANDA process is "abbreviated" because generic manufacturers don't need to repeat the expensive clinical trials that the original manufacturer conducted. Bioequivalence studies are typically conducted on 24–36 healthy volunteers and cost a fraction of full clinical trials.

NADAC gap in this catalogue

Among 147 drugs with both a brand and a generic NADAC unit price, the percent gap runs 4.1 to 99.9% (mean 85.1%). That is not a 30 to 90% band, and it is not a monthly retail quote.

When the label is not a price map

FDA bioequivalence and CMS NADAC are separate files. This catalogue also flags a few registry classes where inactive ingredients or substitution rules are documented differently:

• Narrow therapeutic index (NTI) drugs such as warfarin, levothyroxine, and some anti-seizure products. See the NTI guide for the FDA substitution note, not a switch instruction.
• Inactive ingredients can differ (dyes, fillers). The NADAC row does not list them; the Structured Product Label on the drug page does.
• Extended-release formulations still have to meet the FDA bioequivalence window; this extract does not measure release curves.

Common myths about generics

"Generics are made in inferior facilities"

False. The FDA inspects generic manufacturing facilities with the same rigor as brand name facilities. In fact, many brand name companies also manufacture generics.

"Generics don't work as well"

False. FDA bioequivalence testing ensures generic drugs deliver the same therapeutic effect. Multiple studies have confirmed equivalent outcomes for generics across drug categories.

"Doctors prefer brand name drugs"

Mostly false. Most physicians routinely prescribe generics when available. The American Medical Association encourages generic prescribing to reduce healthcare costs.

Authorized Generics vs Standard Generics

An authorized generic is produced by the brand name manufacturer (or with their permission) and sold under a generic label. These are identical to the brand name product in every way, including inactive ingredients. Standard generics may have different inactive ingredients but the same active drug.